FOLFOX - Folinsäure tatsächlich verabreicht - MII IG Kerndatensatz-Modul Onkologie v2027.0.0-ballot.1

MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 - Germany

This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example MedicationStatement: FOLFOX - Folinsäure tatsächlich verabreicht

English

Profile: MII PR Onkologie Systemische Therapie Medikation

basedOn: CarePlan: identifier = Tumorkonferenz_FOLFOX_001; status = active; intent = plan; category = prätherapeutische Tumorkonferenz (Festlegung der Therapiestrategie); created = 2024-03-10

partOf: Procedure Nicht komplexe Chemotherapie

status: Completed

medication: Leucovorin (Folinsäure)

subject: Hans Schmidt Male, DoB: 1959-03-15 ( https://www.medizininformatik-initiative.de/fhir/sid/patienten#FOLFOX-2024-001)

effective: 2024-03-20 --> 2024-09-15

note:

FOLFOX4

IG © 2022+ Medizininformatik Initiative. Package de.medizininformatikinitiative.kerndatensatz.onkologie#2027.0.0-ballot.1 based on FHIR 4.0.1. Generated 2026-09-15
Links: Table of Contents | QA Report | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Legal notice
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.